If you've started a GLP-1 medication, you may have wondered why your dose is so low at first. Maybe you've even felt tempted to jump ahead faster. This is for you.
The way you climb the dose ladder matters as much as which medication you're on. Done right, GLP-1 dose titration is what keeps side effects manageable and keeps you on treatment long enough to see results.
Our practice, Texas Obesity Medicine, is physician-led by Dr. Tran Le, MD, DABOM, triple board-certified in Obesity Medicine, Addiction Medicine, and Occupational and Environmental Medicine. Here's how we think about titration for patients across Texas and Utah.
What GLP-1 dose titration means (and why "start low, go slow")
Titration simply means starting at a low dose and increasing it in planned steps over weeks. Both semaglutide and tirzepatide are designed this way on purpose.
These medications work in part by acting on your brain and gut. They lower your appetite, help you feel full sooner, and slow down how fast food leaves your stomach (called gastric emptying). That slowing is a big reason a low starting dose matters.
Because the medication changes how quickly your stomach empties, ramping up too fast can overwhelm your system. One review found that this slow-down can cause gastrointestinal (GI) issues, like nausea, diarrhea, and vomiting, and these problems tend to show up right after a dose increase. The gradual schedule gives your body time to adjust at each step, which is exactly the point.
The official guidance reflects this. For semaglutide, your doctor will probably start you on a low dose of semaglutide injection and increase your dose after 4 weeks. Your doctor may increase your dose again after another 4 weeks based on your body's response to the medication.
The typical titration schedules
Every plan is individualized, but the standard ladders look like this.
Semaglutide
Injectable semaglutide follows a step-by-step increase in dose. Per FDA prescribing information, the injection schedule looks like this:
- Weeks 1 to 4: 0.25 mg subcutaneously once a week
- Weeks 5 to 8: 0.5 mg
- Weeks 9 to 12: 1 mg
- Weeks 13 to 16: 1.7 mg
- Week 17 onward (maintenance dose): 1.7 mg or 2.4 mg subcutaneously once a week
As of this year, the FDA approved high-dose Wegovy (semaglutide) for patients who might need the extra push beyond 2.4 mg per week. You can discuss whether 7.2 mg per week of semaglutide is appropriate for you during a consultation with Dr. Le.
Tirzepatide
Tirzepatide is a dual GLP-1/GIP medication and has a longer climb. In the pivotal obesity program, the starting dose is 2.5 mg for 4 weeks. After that, the dose increases by 2.5 mg every 4 weeks (2.5, then 5, then 7.5, then 10, then 12.5, then 15 mg), up to 15 mg or the highest dose you tolerate.
That means most people reach a maintenance dose over roughly 16 to 20 weeks. In the trial protocols, the escalation period for tirzepatide is considered to be 20 weeks to reach the 15 mg maintenance dose.
Want a plain-English breakdown of these two medications side by side? See our medications overview, our semaglutide page, and our tirzepatide page.
Why rushing backfires
In our practice, the patients who struggle most are usually the ones who tried to sprint to the top dose. The escalation schedule exists to ease GI side effects. The trial protocols say it plainly: doctors designed the tirzepatide and semaglutide dose schedules to keep GI symptoms from becoming intolerable.
Higher doses cause more side effects when they're introduced too quickly. Drugs.com summarizes the evidence plainly: higher doses are linked to more GI side effects, especially nausea, while gradual titration lets the body adapt.
The reassuring part is that the slow ladder doesn't cost you results. Clinical trials of GLP-1 medications like semaglutide and tirzepatide show that slow, structured titration improves tolerability and still delivers substantial weight loss and glucose benefits over time.
A quick, important note: staying on schedule is not the same as always reaching the maximum dose. Not everyone needs the highest strength, and your clinician may keep you at a mid-range dose if you're doing well there. That's a feature of good care, not a shortcut.
When it's okay to slow down or hold
Good titration is a conversation, not an autopilot. In our clinic, before each increase we ask how you actually felt on the current dose, not just whether you tolerated it.
If a step brings on rough nausea, holding at the current dose for an extra few weeks is often smarter than pushing ahead. Pausing escalation is almost always better than quitting the medication entirely.
We also individualize based on your response. Some people get excellent appetite control and steady progress at an intermediate dose and simply stay there. Others need to keep climbing.
Both are normal. This is exactly the kind of judgment a physician-led telehealth program is built for.
A brief reminder: this article is educational and isn't a substitute for personal medical advice. Compounded medications are not FDA-approved, and any dose change should be made with your prescriber.
Frequently asked questions
How long does it take to reach a maintenance GLP-1 dose?
For semaglutide, most people reach maintenance around weeks 16 to 17, and for tirzepatide it's typically around weeks 16 to 20. The escalation period for tirzepatide is considered to be 20 weeks to reach the 15 mg maintenance dose, plus an additional 4 weeks to reach steady-state.
For semaglutide, the escalation period is considered to be 8 weeks to reach the 1 mg maintenance dose, plus an additional 4 weeks to reach steady-state. Your exact timeline depends on tolerance and response.
Can I skip a dose level to lose weight faster?
We don't recommend it. Faster titration doesn't guarantee faster results, and it dramatically raises the odds of nausea and vomiting that make people quit. The medication also needs consistent weekly dosing over weeks to build up, which is another reason the ladder is built the way it is.
What if I miss a dose or have a gap?
Tell your provider. After a longer gap, many patients need to re-titrate rather than resume at their previous dose, because the same GI adaptation applies when you restart. Never double up to "catch up."
Start with a plan built around you
The right medication matters, but the right titration is what turns a prescription into steady, livable progress. Our all-inclusive memberships include your compounded semaglutide or tirzepatide and the clinical guidance to escalate at the pace your body can handle. See our pricing for details.
If you're in Texas or Utah and ready to start with a physician-led team, begin your consultation here.
Sources
- MedlinePlus: Semaglutide Injection
- Mayo Clinic: Semaglutide (subcutaneous route)
- Drugs.com: Semaglutide Dosage Guide (FDA prescribing information)
- Drugs.com: What should I expect when my GLP-1 dose increases?
- The American Journal of Medicine: Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss
- Tirzepatide obesity study protocol (ClinicalTrials.gov)
- Tirzepatide/semaglutide GI-management study protocol (ClinicalTrials.gov)